Advertisement

Silver-coated megaprostheses: review of the literature

  • Tom Schmidt-BraeklingEmail author
  • Arne Streitbuerger
  • Georg Gosheger
  • Friedrich Boettner
  • Markus Nottrott
  • Helmut Ahrens
  • Ralf Dieckmann
  • Wiebke Guder
  • Dimosthenis Andreou
  • Gregor Hauschild
  • Burkhard Moellenbeck
  • Wenzel Waldstein
  • Jendrik Hardes
General Review • HIP - ARTHROPLASTY

Abstract

Periprosthetic infection remains one of the most serious complications following megaendoprostheses. Despite a large number of preventive measures that have been introduced in recent years, it has not been possible to further reduce the rate of periprosthetic infection. With regard to metallic modification of implants, silver in particular has been regarded as highly promising, since silver particles combine a high degree of antimicrobial activity with a low level of human toxicity. This review provides an overview of the history of the use of silver as an antimicrobial agent, its mechanism of action, and its clinical application in the field of megaendoprosthetics. The benefits of silver-coated prostheses could not be confirmed until now. However, a large number of retrospective studies suggest that the rate of periprosthetic infections could be reduced by using silver-coated megaprostheses.

Keywords

Silver Megaprosthesis Periprosthetic infection Infection prevention 

Notes

Acknowledgements

A. Streitbuerger receives research support from Implantcast. G. Gosheger obtains royalties for patent with Implantcast. F. Boettner is a consultant for Smith and Nephew, OrthoDevelopement and DePuy.

Compliance with ethical standards

Conflict of interest

G. Gosheger has patent silver with royalties paid. F. Boettner is a consultant for Smith and Nephew, OrthoDevelopement and DePuy. The other authors (T.S.B., A.S., M.N., H.A., R.D., W.G., D.A., G.H., B.M., W.W., and J.H.) declare that there is no conflict of interest regarding the publication of this paper.

References

  1. 1.
    Gosheger G, Gebert C, Ahrens H, Streitbuerger A, Winkelmann W, Hardes J (2006) Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res 450:164–167CrossRefPubMedGoogle Scholar
  2. 2.
    Hardes J, Gebert C, Schwappach A et al (2006) Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg 126(5):289–296CrossRefPubMedGoogle Scholar
  3. 3.
    Jeys LM, Luscombe JS, Grimer RJ, Abudu A, Tillman RM, Carter SR (2007) The risks and benefits of radiotherapy with massive endoprosthetic replacement. J Bone Joint Surg (British) 89(10):1352–1355CrossRefGoogle Scholar
  4. 4.
    Jeys LM, Grimer RJ, Carter SR, Tillman RM (2005) Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg (American) 87(4):842–849Google Scholar
  5. 5.
    Kumar D, Grimer RJ, Abudu A, Carter SR, Tillman RM (2003) Endoprosthetic replacement of the proximal humerus. long-term results. J Bone Joint Surg (British) 85(5):717–722Google Scholar
  6. 6.
    Funovics PT, Hipfl C, Hofstaetter JG, Puchner S, Kotz RI, Dominkus M (2011) Management of septic complications following modular endoprosthetic reconstruction of the proximal femur. Int Orthop 35(10):1437–1444CrossRefPubMedGoogle Scholar
  7. 7.
    Grimer RJ, Carter SR, Tillman RM et al (1999) Endoprosthetic replacement of the proximal tibia. J Bone Joint Surg (British) 81(3):488–494CrossRefGoogle Scholar
  8. 8.
    Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M (2013) High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res 471(6):2017–2027CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Hardes J, von Eiff C, Streitbuerger A et al (2010) Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 101(5):389–395PubMedGoogle Scholar
  10. 10.
    Veerachamy S, Yarlagadda T, Manivasagam G, Yarlagadda PK (2014) Bacterial adherence and biofilm formation on medical implants: a review. Proc Inst Mech Eng Part H J Eng Med 228(10):1083–1099CrossRefGoogle Scholar
  11. 11.
    Eltorai AE, Haglin J, Perera S et al (2016) Antimicrobial technology in orthopedic and spinal implants. World J Orthop 7(6):361–369CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Arciola CR, Campoccia D, An YH et al (2006) Prevalence and antibiotic resistance of 15 minor staphylococcal species colonizing orthopedic implants. Int J Artif Organs 29(4):395–401PubMedGoogle Scholar
  13. 13.
    Darouiche RO (2004) Treatment of infections associated with surgical implants. N Engl J Med 350(14):1422–1429CrossRefPubMedGoogle Scholar
  14. 14.
    DeJong ES, DeBerardino TM, Brooks DE et al (2001) Antimicrobial efficacy of external fixator pins coated with a lipid stabilized hydroxyapatite/chlorhexidine complex to prevent pin tract infection in a goat model. J Trauma 50(6):1008–1014CrossRefPubMedGoogle Scholar
  15. 15.
    Ho KM, Litton E Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis J Antimicrob Chemother 58(2) pp. 281–287 (2006). Erratum in J Antimicrob Chemother 65(4) pp. 815 (2010)Google Scholar
  16. 16.
    Gosheger G, Hardes J, Ahrens H et al (2004) Silver-coated megaendoprostheses in a rabbit model—an analysis of the infection rate and toxicological side effects. Biomaterials 25(24):5547–5556CrossRefPubMedGoogle Scholar
  17. 17.
    Alexander JW (2009) History of the medical use of silver. Surg Infect 10(3):289–292CrossRefGoogle Scholar
  18. 18.
    Koller J (2004) Topical treatment of partial thickness burns by silver sulfadiazine plus hyaluronic acid compared to silver sulfadiazine alone: a double-blind, clinical study. Drugs Exp Clin Res 30(5–6):183–190PubMedGoogle Scholar
  19. 19.
    Brutel de la Riviere A, Dossche KM, Birnbaum DE, Hacker R (2000) First clinical experience with a mechanical valve with silver coating. J Heart Valve Dis 9(1):123–130PubMedGoogle Scholar
  20. 20.
    Politano AD, Campbell KT, Rosenberger LH, Sawyer RG (2013) Use of silver in the prevention and treatment of infections: silver review. Surg Infect 14(1):8–20CrossRefGoogle Scholar
  21. 21.
    Clement JL, Jarrett PS (1994) Antibacterial silver. Met-based Drugs 1(5–6):467–482CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Gupta A, Phung LT, Taylor DE, Silver S (2001) Diversity of silver resistance genes in IncH incompatibility group plasmids. Microbiology 147(12):3393–3402CrossRefPubMedGoogle Scholar
  23. 23.
    Alt V, Bechert T, Steinrücke P et al (2004) Nanoparticulate silver. A new antimicrobial substance for bone cement. Orthopade 33(8):885–892CrossRefPubMedGoogle Scholar
  24. 24.
    Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ (1997) Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis 6(5):553–561PubMedGoogle Scholar
  25. 25.
    Wan AT, Conyers RA, Coombs CJ, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37(10):1683–1687PubMedGoogle Scholar
  26. 26.
    Rosenman KD, Moss A, Kon S (1979) Argyria: clinical implications of exposure to silver nitrate and silver oxide. J Occup Med 21(6):430–435PubMedGoogle Scholar
  27. 27.
    Hardes J, Ahrens H, Gebert C et al (2007) Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials 28(18):2869–2875CrossRefPubMedGoogle Scholar
  28. 28.
    Glehr M, Leithner A, Friesenbichler J et al (2013) Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J 95(7):988–992CrossRefPubMedGoogle Scholar
  29. 29.
    Scoccianti G, Frenos F, Beltrami G, Campanacci DA, Capanna R (2016) Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury 47(Supplement 4):S11–S16CrossRefPubMedGoogle Scholar
  30. 30.
    Donati F, Di Giacomo G, D’Adamio S et al (2016) Silver-coated hip megaprosthesis in oncological limb savage [sic] surgery. Biomed Res Int 2016:6 (Article ID 9079041) CrossRefGoogle Scholar
  31. 31.
    Wafa H, Grimer RJ, Reddy K et al (2015) Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J 97(2):252–257CrossRefPubMedGoogle Scholar
  32. 32.
    Wilding CP, Cooper GA, Freeman AK, Parry MC, Jeys L (2016) Can a silver-coated arthrodesis implant provide a viable alternative to above knee amputation in the unsalvageable, infected total knee arthroplasty? J Arthroplast 31(11):2542–2547CrossRefGoogle Scholar
  33. 33.
    Hardes J, Streitburger A, Ahrens H et al (2007) The influence of elementary silver versus titanium on osteoblasts behaviour in vitro using human osteosarcoma cell lines. Sarcoma 2007:5 (Article ID 26539) CrossRefGoogle Scholar
  34. 34.
    Hauschild G, Hardes J, Gosheger G et al (2015) Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model. Biomed Res Int 2015:10 (Article ID 292406) CrossRefGoogle Scholar
  35. 35.
    Schierholz JM, Lucas LJ, Rump A, Pulverer G (1998) Efficacy of silver-coated medical devices. J Hosp Infect 40(4):257–262CrossRefPubMedGoogle Scholar
  36. 36.
    Randall CP, Gupta A, Jackson N, Busse D, O’Neill AJ (2015) Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms. J Antimicrob Chemother 70(4):1037–1046PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag France 2017

Authors and Affiliations

  • Tom Schmidt-Braekling
    • 1
    Email author
  • Arne Streitbuerger
    • 1
  • Georg Gosheger
    • 1
  • Friedrich Boettner
    • 2
  • Markus Nottrott
    • 1
  • Helmut Ahrens
    • 1
  • Ralf Dieckmann
    • 1
  • Wiebke Guder
    • 1
  • Dimosthenis Andreou
    • 1
  • Gregor Hauschild
    • 1
  • Burkhard Moellenbeck
    • 1
  • Wenzel Waldstein
    • 3
  • Jendrik Hardes
    • 1
  1. 1.Department of Orthopedics and Tumor OrthopedicsMuenster University HospitalMuensterGermany
  2. 2.Adult Reconstruction and Joint Replacement Division, Hospital for Special SurgeryWeill Medical College of Cornell UniversityNew YorkUSA
  3. 3.Department of Orthopedics, Vienna General HospitalMedical University of ViennaViennaAustria

Personalised recommendations